| Primary |
| Angioimmunoblastic T-cell Lymphoma |
12.2% |
| Lung Neoplasm Malignant |
10.8% |
| Rheumatoid Arthritis |
8.1% |
| T-cell Lymphoma Stage Iv |
8.1% |
| Testicular Germ Cell Cancer |
8.1% |
| Immunosuppressant Drug Therapy |
5.4% |
| Prophylaxis Against Transplant Rejection |
5.4% |
| Breast Cancer Metastatic |
4.1% |
| Multiple Myeloma |
4.1% |
| Non-hodgkin's Lymphoma |
4.1% |
| Pericardial Neoplasm |
4.1% |
| T-cell Lymphoma Refractory |
4.1% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
2.7% |
| Idiopathic Pneumonia Syndrome |
2.7% |
| Lupus Nephritis |
2.7% |
| Multiple Sclerosis |
2.7% |
| Nephrotic Syndrome |
2.7% |
| Pemphigus |
2.7% |
| Postoperative Care |
2.7% |
| Radiation Pneumonitis |
2.7% |
|
| Neutropenia |
18.8% |
| Cerebral Thrombosis |
9.4% |
| Oedema |
6.3% |
| Renal Failure |
6.3% |
| Renal Impairment |
6.3% |
| Reversible Posterior Leukoencephalopathy Syndrome |
6.3% |
| Thrombosis |
6.3% |
| Acne |
3.1% |
| Bone Density Decreased |
3.1% |
| Drug Intolerance |
3.1% |
| Electrocardiogram Qt Corrected Interval Prolonged |
3.1% |
| Encephalopathy |
3.1% |
| Erysipelas |
3.1% |
| Flushing |
3.1% |
| Hallucination |
3.1% |
| Herpes Oesophagitis |
3.1% |
| Hypertrophic Cardiomyopathy |
3.1% |
| Infection |
3.1% |
| Joint Swelling |
3.1% |
| Loss Of Consciousness |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.0% |
| Acute Lymphocytic Leukaemia |
15.0% |
| Rheumatoid Arthritis |
9.3% |
| Prophylaxis |
7.6% |
| Central Nervous System Lymphoma |
6.7% |
| Renal Transplant |
4.4% |
| Infection Prophylaxis |
4.3% |
| Thrombosis Prophylaxis |
4.0% |
| Hypertension |
3.8% |
| Prophylaxis Against Transplant Rejection |
3.6% |
| Wegener's Granulomatosis |
3.0% |
| Liver Transplant |
3.0% |
| Glomerulonephritis |
2.4% |
| Immunosuppression |
2.4% |
| Status Asthmaticus |
2.4% |
| Anxiety |
2.3% |
| Nephrotic Syndrome |
2.1% |
| Lupus Nephritis |
1.8% |
| Anxiety Disorder |
1.5% |
| Lung Transplant |
1.5% |
|
| Transplant Rejection |
11.4% |
| Respiratory Distress |
6.8% |
| Interstitial Lung Disease |
6.1% |
| Leukoencephalopathy |
6.1% |
| Proteinuria |
6.1% |
| Spinal Disorder |
6.1% |
| Progressive Multifocal Leukoencephalopathy |
5.3% |
| Weight Increased |
5.3% |
| Epstein-barr Virus Antigen Positive |
4.5% |
| Pyrexia |
4.5% |
| Sepsis |
4.5% |
| Vomiting |
4.5% |
| Diabetes Mellitus |
3.8% |
| Drug Ineffective |
3.8% |
| Neutropenia |
3.8% |
| Respiratory Failure |
3.8% |
| Urine Analysis Abnormal |
3.8% |
| Weight Decreased |
3.8% |
| Central Nervous System Lymphoma |
3.0% |
| Cerebrovascular Accident |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.9% |
| Rheumatoid Arthritis |
19.2% |
| Renal Transplant |
5.8% |
| Immunosuppressant Drug Therapy |
5.4% |
| Prophylaxis |
4.8% |
| Premedication |
4.1% |
| Hypertension |
3.5% |
| Psoriatic Arthropathy |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Multiple Sclerosis Relapse |
2.2% |
| Liver Transplant |
2.1% |
| Prophylaxis Against Transplant Rejection |
2.1% |
| Relapsing-remitting Multiple Sclerosis |
2.1% |
| Immunosuppression |
2.0% |
| Systemic Lupus Erythematosus |
2.0% |
| Vitamin Supplementation |
1.9% |
| Arthritis |
1.8% |
| Asthma |
1.8% |
| Hiv Infection |
1.8% |
| Stem Cell Transplant |
1.8% |
|
| Vomiting |
11.6% |
| Urticaria |
7.1% |
| Pulmonary Oedema |
6.6% |
| Bilirubin Conjugated Increased |
6.1% |
| Respiratory Tract Infection |
6.1% |
| Weight Decreased |
6.1% |
| Pyrexia |
5.6% |
| Respiratory Failure |
5.6% |
| Thrombotic Microangiopathy |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Pneumonia |
4.0% |
| Sepsis |
4.0% |
| Thrombocytopenia |
4.0% |
| Transplant Rejection |
4.0% |
| Wheezing |
4.0% |
| Pleural Effusion |
3.5% |
| Tumour Lysis Syndrome |
3.5% |
| Diarrhoea |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Pulmonary Embolism |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
33.3% |
| Essential Hypertension |
16.7% |
| Hypertension |
16.7% |
| Nasopharyngitis |
16.7% |
| Bladder Disorder |
8.3% |
| Tobacco User |
8.3% |
|
| Drug Interaction |
66.7% |
| Weight Increased |
33.3% |
|
